Innovations in healthcare often require fine tuning of the Healthcare System (HCS). This also applies to RadioLigand Therapies (RLT), a novel way of treating cancer patients, for which it's imperative that Healthcare System Stakeholders work together. 🎥 This Webinar will share what we've learned so far and what needs to happen to prepare HCS and to ensure patients have timely and equitable access to Radioligand Therapies #RLT Register below to hear from an exquisite panel of experts! 🔽
🎙️New speaker just added to IQVIA Institute's webinar Succeeding with Innovation: State of Radioligand Therapy Readiness in Europe. Join a panel of experts for a discussion on the level of readiness for radioligand therapy (RLT) in different European countries. Speakers include: Margarida Goulart Ken Herrmann frederic courbon Panos Kanavos, Ph.D Jayne Spink Ph.D. Jasminka Taleska Register here: https://lnkd.in/gqrQzEpy Panagiota (Penny) Papaioannou, Leonhard Schaetz, Linda Chong, MBA, MSc, MPhil, Murray Aitken
